Aclaris Therapeutics, Inc. (ACRS) has a market capitalization of $472.73M and trades at $3.92. The 52-week range is 1.05-4.89.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -7.4, Earnings Per Share (EPS) of $-0.53, annual revenue of $7.83M.
The stock has a beta of 0.68, operates in the Healthcare sector.
